Submissions

Online Submissions

Already have a Username/Password for Journal of Tumor?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

 

Author Guidelines

Author Guidelines

Journal of Tumor (ISSN 1819-6187) is a bimonthly, open accessed, peer reviewed journal. The journal welcomes original significant and up-to-date articles on all aspects of experimental and clinical oncology.

Scope of the journal covers: JT publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. The journal publishes research papers in areas of research include, but are not limited to, the following: Clinical diagnosis, laboratory diagnosis, differential diagnosis, imaging tests, pathological diagnosis, molecular biological diagnosis, immunological diagnosis, genetic diagnosis, functional diagnostics, and physical diagnosis; and comprehensive therapy, drug therapy, surgical therapy, interventional treatment, minimally invasive therapy, and robot-assisted therapy.

Open Access Policy

The biggest advantage of the OA model is that it provides free, full-text articles in PDF and other formats for experts and the public without registration, which eliminates the obstacle that traditional journals possess and usually delays the speed of the propagation and communication of scientific research results. The open access model has been proven to be a true approach that may achieve the ultimate goal of the journals, i.e. the maximization of the value to the readers, authors and society.

Published by

ACT Publishing Group Ltd.

Online submissions

Manuscripts should be submitted through the Online Submission System at: http://www.ghrnet.org/index.php/JT. For assistance, authors encountering problems with the Online Submission System may send an email describing the problem to tumor@ghrnet.org

MANUSCRIPT PREPARATION

All contributions should be written in English. Spelling should be US English or British English, but not a mixture. All articles must be submitted using word-processing software. There is no explicit limit on the length of articles submitted, but authors are encouraged to be concise. There is no restriction on the number of figures or tables. Figures and tables should be sequentially referenced. Authors should include all relevant supporting data with each article. The editing is only to correct such things as misused words, spelling errors, missing references or incomplete citation information. Authors are advised to write clearly and simply, and to have their article checked by colleagues before submission. Non-native speakers of English may choose to make use of a copyediting service. Required information for each of the manuscript sections is as follows:

Title page

The title should be short, informative and contain the major key words. Articles with a title longer than the 120 character limitation may not be sent out for review. A short running title (less than 40 characters, including spaces) should also be provided.

Authorship: (1) The full names of the authors and the addresses of the institutions at which the work was carried out together with the full postal address and email address, plus facsimile and telephone number of the author to whom correspondence about the manuscript, proofs and requests for off prints should be sent. Authorship credit should be in accordance with the standard proposed by ICMJE, based on (1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be published. Authors should meet conditions 1, 2, and 3.

Abstract and Key words

Original articles must have a structured abstract that states in 250 words or less the purpose, basic procedures, main findings and principal conclusions of the study. Divide the abstract with the headings:

AIM, MATERIALS AND METHODS, RESULTS and CONCLUSION. The abstracts of reviews need not be structured. The abstract should not contain abbreviations or references. Three to five keywords should be supplied below the abstract and should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser - (http://www.nlm.nih.gov/mesh/meshhome.html).

Text

Authors should use subheadings to divide the sections of their manuscript: Introduction, Methods, Results, Discussion, Acknowledgments and References.

Figures

Figures should be numbered as 1, 2, 3, etc., and mentioned clearly in the main text. Provide a brief title for each figure on a separate page. Detailed legends should not be provided under the figures. This part should be added into the text where the figures are applicable. Low resolution images will be sufficient for the review process, but upon acceptance authors will be asked to supply high-resolution images or original figures for publication. Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce figures or tables that have previously been published elsewhere. The following file formats can be accepted: Microsoft Word (version 5 and above; figures must be a single page); PowerPoint (figures must be a single page); TIFF and JPEG.

Tables

Three-line tables should be numbered in sequence using Arabic numerals (i.e. Table 1, 2, 3 etc.), and mentioned clearly in the main text. Provide a brief title that summarizes the whole table, maximum 15 words for each table. Detailed legends should not be included under tables, but rather added into the text where applicable. The information should complement, but not duplicate the text. All abbreviations should be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. The table and its legend/footnotes should be understandable without reference to the text.

Acknowledgments

The source of financial grants and other funding should be acknowledged, including a frank declaration of the authors' industrial links and affiliations. In the case of clinical trials or any article describing use of a commercial device, therapeutic substance or food must state whether there are any potential conflicts of interest for each of the authors: failure to make such a statement may jeopardize the article being sent out for peer-review. The contribution of colleagues or institutions should also be acknowledged. Thanks to anonymous reviewers are not allowed.

List of abbreviations

If abbreviations are used in the text either they should be defined in the text where first used, or a list of abbreviations can be provided, which should precede the competing interests.

REFERENCES

Coding system

We recommend the use of a tool such as EndNote or Reference Manager for reference management and formatting. The author should number the references in Arabic numerals according to the citation order in the text. Put reference numbers in square brackets in superscript at the end of citation content or after the cited author’s name. When the authors write the references, please ensure that the order in text is the same as in the references section, and also ensure the spelling accuracy of the first author’s name. Do not list the same citation twice.

Style for journal references

English journal article (list all authors and include the PMID where applicable)

Jung EM, Clevert DA, Schreyer AG, Schmitt S, Rennert J, Kubale R, Feuerbach S, Jung F. Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: A prospective controlled two-center study. World J Gastroenterol 2007; 13: 6356-6364

Style for Electronic journal

Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis serial online, 1995-01-03, cited 1996-06-05; 1(1): 24 screens. Available from: URL: http://www.cdc.gov/ncidod/eid/index.htm

Style for book references

Sherlock S, Dooley J. Diseases of the liver and billiary system. 9th ed. Oxford: Blackwell Sci Pub, 1993: 258-296

Publication and peer review processes

Submitted manuscripts will be sent to peer reviewers, unless they are either out of scope or below threshold for the journal, or the presentation or written English is of an unacceptably low standard. They will generally be reviewed by two experts with the aim of reaching a first decision as soon as possible. We ask all authors to provide the contact details (including email addresses) of at least four potential peer reviewers for their manuscript. These should be experts in their field of study, who will be able to provide an objective assessment of the manuscript. Any suggested peer reviewers should not have published with any of the authors of the manuscript within the past five years and should not be members of the same research institution, nor should they be on the Editorial Board of the journal unless they work precisely in that field. Suggested reviewers will be considered alongside potential reviewers identified by their publication record or recommended by Editorial Board members.

Copyright Form
Authors publishing in the Journal will be asked to sign a Copyright Transfer Agreement. In signing the form it is assumed that authors have obtained permission to use any copyrighted or previously published material. All authors must read and agree to the conditions outlined in the form, and must sign the form or agree that the corresponding author can sign on their behalf. Articles cannot be published until a signed form has been received.

Publication fee

If this paper is accepted for publication, you will be asked to pay an Article Publication Fee to cover publications costs. The related standards are as follows. Publication fee: 360 USD per article. Editorial, Topic Highlight and letters to the editor are published free of charge. JT will waive publication fees for authors in financial difficulty.


PUBLICATION AND PEER REVIEW PROCESSES

Submitted manuscripts will be sent to peer reviewers, unless they are either out of scope or below threshold for the journal, or the presentation or written English is of an unacceptably low standard. They will generally be reviewed by two experts with the aim of reaching a first decision as soon as possible. Editors send four reviewers the request to review with the submission attached to the email. Reviewers email editors their assent (or regrets), as well as the review and recommendation. In order to facilitate the editing process and to improve the efficiency of JT, all peer reviewers are requested to return their comments within two weeks. All reviewers must keep the manuscripts confidential. They must not give the manuscript to any third party, or discuss the contents of the articles with the authors of the manuscript or other persons. If the reviewers feel that there is an interest conflict with the authors, personally, academically or economically, then the reviewer must inform the Editorial Office immediately.

 

PUBLISHED STATEMENT OF INFORMED CONSENT

Manuscripts should contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee or it should be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted. Authors should also draw attention to the Code of Ethics of the World Medical Association (Declaration of Helsinki, 1964, as revised in 2004).

 

PUBLISHED STATEMENT OF HUMAN AND ANIMAL RIGHTS

When reporting the results from experiments, authors should follow the highest standards and the trial should comform to Good Clinical Practice (for example, US Food and Drug Administration Good Clinical Practice in FDA-Regulated Clinical Trials; UK Medicines Research Council Guidelines for Good Clinical Practice in Clinical Trials) and/or the World Medical Association Declaration of Helsinki. Generally, we suggest authors follow the lead investigator’s national standard. If doubt exists whether the research was conducted in accordance with the above standards, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.

Before submitting, authors should make their study approved by the relevant research ethics committee or institutional review board. If human participants were involved, manuscripts must be accompanied by a statement that the experiments were undertaken with the understanding and appropriate informed consent of each. Any personal item or information will not be published without explicit consents from the involved patients. If experimental animals were used, the materials and methods (experimental procedures) section must clearly indicate that appropriate measures were taken to minimize pain or discomfort, and details of animal care should be provided.

 

GUIDELINES FOR FILING A COMPETING INTEREST STATEMENT

In the interests of transparency and to help reviewers assess any potential bias, Journal of  Tumor requires authors of all papers to declare any competing commercial, personal, political, intellectual, or religious interests in relation to the submitted work. Referees are also asked to indicate any potential conflict they might have reviewing a particular paper. Before submitting, authors are suggested to read “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Ethical Considerations in the Conduct and Reporting of Research: Conflicts of Interest” from International Committee of Medical Journal Editors (ICMJE), which is available at:http://www.icmje.org/ethical_4conflicts.html.



 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  2. The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
  3. Where available, URLs for the references have been provided.
  4. The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  5. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  6. If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.
 

Copyright Notice

Submission of a manuscript implies that the work described is not simultaneously being considered by other journals or is already published elsewhere; That the material contained within the manuscript is original, with all information from other sources appropriately referenced, and that written specific permission has been granted by any existing copyright holders prior to publication and is clearly cited and available. That its publication has been approved by all co-authors; That the author(s) agree to transfer to ACT Publishing Group Inc exclusive copyright ownership for all formats of the manuscript, including print and electronic formats, English and non-English language formats, and subsequent editions; That the author(s) acknowledge that all articles published by ACT Publishing Group Inc are selected by an in-house editor and fully peer-reviewed by external reviewers. ACT Publishing Group Inc applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. The corresponding author and all co-authors, signs a copyright transfer form at the time of submission of the manuscript; That all figures and tables have been correctly placed and clearly identified, and meet the journal’s standards of high-resolution quality. The Journal or the publisher will not be held legally responsible should there be any claims for compensation. The journal allows the authors to hold the copyright without restrictions and to retain publishing rights without restrictions.

 

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

 

Author Fees

This journal charges the following author fees.

Article Submission: 0.00 (USD)
Authors are required to pay an Article Submission Fee as part of the submission process to contribute to review costs.

Fast-Track Review: 0.00 (USD)
With the payment of this fee, the review, editorial decision, and author notification on this manuscript is guaranteed to take place within 4 weeks.

Article Publication: 360.00 (USD)
If this paper is accepted for publication, you will be asked to pay an Article Publication Fee to cover publications costs.

If you do not have funds to pay such fees, you will have an opportunity to waive each fee. We do not want fees to prevent the publication of worthy work.



ISSN: 1819-6187